Capital International Investors - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
Capital International Investors ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$83,583,371
-6.5%
2,446,820
+5.4%
0.02%
-4.5%
Q2 2023$89,396,654
+7.6%
2,321,9910.0%0.02%
+4.8%
Q1 2023$83,104,058
+0.4%
2,321,991
+10.6%
0.02%
-4.5%
Q4 2022$82,786,400
+39.6%
2,099,579
+27.8%
0.02%
+29.4%
Q3 2022$59,295,000
+23.2%
1,642,508
+3.8%
0.02%
+30.8%
Q2 2022$48,140,000
+81.4%
1,582,508
+82.3%
0.01%
+116.7%
Q1 2022$26,544,000
-19.5%
868,297
-17.8%
0.01%
-14.3%
Q4 2021$32,981,000
+104.5%
1,055,7260.0%0.01%
+75.0%
Q3 2021$16,131,000
-17.9%
1,055,7260.0%0.00%0.0%
Q2 2021$19,658,000
+4.0%
1,055,7260.0%0.00%
-20.0%
Q1 2021$18,897,000
+16.4%
1,055,7260.0%0.01%
+25.0%
Q4 2020$16,237,000
+38.9%
1,055,7260.0%0.00%0.0%
Q3 2020$11,687,000
-11.7%
1,055,7260.0%0.00%0.0%
Q2 2020$13,239,000
+10.6%
1,055,7260.0%0.00%
-20.0%
Q1 2020$11,972,000
-13.5%
1,055,7260.0%0.01%0.0%
Q4 2019$13,841,000
+45.5%
1,055,7260.0%0.01%
+25.0%
Q3 2019$9,512,000
-8.6%
1,055,7260.0%0.00%0.0%
Q2 2019$10,409,000
-3.0%
1,055,7260.0%0.00%
-20.0%
Q1 2019$10,726,000
+81.3%
1,055,726
+12.6%
0.01%
+66.7%
Q4 2018$5,915,000
-52.2%
937,4000.0%0.00%
-50.0%
Q3 2018$12,374,000937,4000.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders